These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1569817

  • 21. Interventions for erythema nodosum leprosum.
    Van Veen NH, Lockwood DN, van Brakel WH, Ramirez J, Richardus JH.
    Cochrane Database Syst Rev; 2009 Jul 08; 2009(3):CD006949. PubMed ID: 19588412
    [Abstract] [Full Text] [Related]

  • 22. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
    Fabi SG, Hill C, Witherspoon JN, Boone SL, West DP.
    J Drugs Dermatol; 2009 Aug 08; 8(8):765-9. PubMed ID: 19663116
    [Abstract] [Full Text] [Related]

  • 23. Preparing for thalidomide's comeback.
    Vanchieri C.
    Ann Intern Med; 1997 Nov 15; 127(10):951-2. PubMed ID: 9446509
    [No Abstract] [Full Text] [Related]

  • 24. Thalidomide in erythema nodosum leprosum.
    Jew LJ, Middleton RK.
    DICP; 1990 May 15; 24(5):482-3. PubMed ID: 2188435
    [No Abstract] [Full Text] [Related]

  • 25. Erythema nodosum leprosum in histoid leprosy: a case report.
    Kumar V, Mendiratta V, Sharma RC, Kakar N, Bajaj P.
    J Dermatol; 1997 Sep 15; 24(9):611-4. PubMed ID: 9350110
    [Abstract] [Full Text] [Related]

  • 26. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
    Ishii N, Ishida Y, Okano Y, Ozaki M, Gidoh M, Kumano K, Goto M, Nogami R, Hatano K, Yamada A, Yotsu RR.
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep 15; 80(3):275-85. PubMed ID: 21941834
    [Abstract] [Full Text] [Related]

  • 27. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM.
    Lepr Rev; 2008 Sep 15; 79(3):254-69. PubMed ID: 19009975
    [Abstract] [Full Text] [Related]

  • 28. Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases.
    Narang T, Kaushik A, Dogra S.
    Br J Dermatol; 2020 Apr 15; 182(4):1034-1037. PubMed ID: 31218666
    [Abstract] [Full Text] [Related]

  • 29. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY, Achirafi A, Flageul B.
    J Dermatol; 2003 Jan 15; 30(1):64-8. PubMed ID: 12598712
    [Abstract] [Full Text] [Related]

  • 30. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP, Malta AM, Sarno EN, Kaplan G.
    Int J Lepr Other Mycobact Dis; 1996 Sep 15; 64(3):268-73. PubMed ID: 8862260
    [Abstract] [Full Text] [Related]

  • 31. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
    Pal D.
    Trop Doct; 2023 Oct 15; 53(4):533-535. PubMed ID: 37401254
    [Abstract] [Full Text] [Related]

  • 32. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
    Sampaio EP, Moraes MO, Nery JA, Santos AR, Matos HC, Sarno EN.
    Clin Exp Immunol; 1998 Feb 15; 111(2):300-8. PubMed ID: 9486396
    [Abstract] [Full Text] [Related]

  • 33. A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
    Bathula S, Sardana K, Mathachan SR, Khurana A, Ahuja A, Paliwal P.
    Int J Dermatol; 2023 Jan 15; 62(1):48-55. PubMed ID: 35924464
    [Abstract] [Full Text] [Related]

  • 34. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J.
    Acta Leprol; 1983 Jan 15; 1(1):41-50. PubMed ID: 6401140
    [No Abstract] [Full Text] [Related]

  • 35. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide.
    Vetrichevvel TP, Pise GA, Thappa DM.
    Lepr Rev; 2008 Jun 15; 79(2):193-5. PubMed ID: 18711941
    [Abstract] [Full Text] [Related]

  • 36. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL, Waters MF, Lockwood DN.
    Lepr Rev; 2007 Sep 15; 78(3):197-215. PubMed ID: 18035771
    [Abstract] [Full Text] [Related]

  • 37. Erythema Necroticans - A Case Report.
    Mehta N, Ramachandran R, Srikanth S.
    Indian J Lepr; 2016 Sep 15; 87(4):255-257. PubMed ID: 29762955
    [Abstract] [Full Text] [Related]

  • 38. Neutrophilic leukocytosis and erythema nodosum leprosum in leprosy: insights from a retrospective observational study.
    Feitosa da Silva Barboza M, de Andrea Hacker M, Maria Sales A, Fontoura Rodrigues D, Pedrosa Marques D, José Ciryllo Silva Noya D, Leal Silveira Andrezo Rosa T, de Fátima Alvim Braga I, Ferreira H, Porto Amadeu T, Gurgel de Oliveira M, de Miranda Machado A, Illarramendi X, Schmitz V.
    Front Immunol; 2024 Sep 15; 15():1368460. PubMed ID: 39072336
    [Abstract] [Full Text] [Related]

  • 39. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH, Sieling PA.
    Int J Lepr Other Mycobact Dis; 1998 Sep 15; 66(3):316-27. PubMed ID: 9934358
    [Abstract] [Full Text] [Related]

  • 40. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK, Srivastava P, Minz A, Verma K.
    Lepr Rev; 2006 Sep 15; 77(3):225-9. PubMed ID: 17172003
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.